M
MaxCyte, Inc. (MXCT)
NMS – Real vaqt narxi. Valyuta: USD
1.27
+0.03 (2.41%)
Bozor ochiq: Aug 12, 2026, 3:37 PM EDT
1.33
+0.09 (7.26%)
Oldingi bozordan keyin: Aug 11, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
1.27
+0.03 (2.41%)
Bozor ochiq: Aug 12, 2026, 3:37 PM EDT
1.33
+0.09 (7.26%)
Oldingi bozordan keyin: Aug 11, 2026, 7:59 PM EDT
MaxCyte, Inc., biotexnologiya kompaniyasi, Qo'shma Shtatlar va xalqaro miqyosda hujayra terapiyasini kashf qiladi, ishlab chiqadi va tijoratlashtiradi. Kompaniyaning mahsulotlari kichik va o'rta miqyosdagi transfektsiya uchun statik elektroporatsiya apparati ExPERT ATx; oqsil ishlab chiqarish va dori vositalarini ishlab chiqish, shuningdek, hujayraga asoslangan tahlillar uchun terapevtik maqsadlarni ifodalash uchun oqimli elektroporatsiya apparati ExPERT STx; terapevtik qo'llanmalarda katta miqyosdagi transfektsiya uchun oqimli elektroporatsiya apparati ExPERT GTx; va juda katta hajmdagi hujayra muhandisligi uchun ExPERT VLx. Shuningdek, u hujayralarni qayta ishlash va elektroporatsiya qilish uchun bir martalik ishlatiladigan qayta ishlash majmuasini (PA) va PAni qo'llab-quvvatlovchi aksessuarlar, masalan, elektroporatsiya tamponi eritmasi va dasturiy protokollarni taqdim etadi. Kompaniya o'zining apparatlari va texnologiyalarini litsenziyalaydi va sotadi; va hujayra terapiyasi ishlab chiquvchilariga, shuningdek, dori vositalarini kashf qilish va ishlab chiqish hamda bio-ishlab chiqarishda foydalanish uchun farmatsevtika va biotexnologiya kompaniyalariga o'zining sarf materiallarini sotadi. Kompaniya yangi genni yetkazib berish yechimini birgalikda ishlab chiqishga qaratilgan VectorBuilder bilan strategik hamkorlikka ega. MaxCyte, Inc. 1998 yilda ro'yxatga olingan va shtab-kvartirasi Merilend shtatining Rokvill shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Jack Horgan | Senior Vice President of Corporate Development |
| Mr. Jay Gelfman | Chief Operations Officer |
| Mr. Maher Masoud | President, CEO & Executive Director |
| Mr. Parmeet Ahuja | Chief Financial Officer |
| Ms. Ana-Paula Martins Fernandes | Senior Vice President of Global Sales |
| Ms. Jill Mayer | Senior Vice President of Human Resources |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-17 | 8-K | mxct-20260617x8k.htm |
| 2026-06-16 | 8-K | mxct-20260610x8k.htm |
| 2026-05-13 | 10-Q | mxct-20260331x10q.htm |
| 2026-05-12 | 8-K | mxct-20260512x8k.htm |
| 2026-04-29 | DEFA14A | ny20071620x2_defa14a.htm |
| 2026-04-29 | DEF 14A | ny20071620x1_def14a.htm |
| 2026-04-29 | ARS | ny20071620x3_ars.pdf |
| 2026-04-15 | S-8 | tm2611297d1_s8.htm |
| 2026-03-27 | 8-K | mxct-20260323x8k.htm |
| 2026-03-25 | 10-K | mxct-20251231x10k.htm |